TXMD — TherapeuticsMD Inc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
$2.22
+$0.05 (+2.10%)
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on NASDAQ. It is led by Marlan D. Walker J.D., based in 951 Yamato Road, Boca Raton, FL, United States, 33431, with about 1 employees. TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Net income was $152.0K. TXMD currently screens at market cap $13.7M.
Use this TXMD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TXMD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TXMD SEC filings page. Lician reads the product cache first so this HTML stays unique to TherapeuticsMD Inc even when a live quote feed is slow.
About TherapeuticsMD Inc
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
TXMD Key Statistics
Market Cap
$13.66M
Volume
60,729
Previous Close
$2.28
Day Range
$2.21 – $2.32
EPS
-$0.19
Revenue
$1.76M
Net Income
-$2.18M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+35.3%
Profit Margin
-123.9%
Employees
1
TXMD Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $1.76M | $1.30M | $69.96M | $18.68M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.18M | -$10.28M | $112.00M | -$42.96M |
| EPS (Diluted) | -$0.19 | -$0.99 | $11.96 | -$21.66 |
Total Assets
$38.82M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$5.06M
Operating Cash Flow
$0.00
Free Cash Flow
$0.00
TherapeuticsMD Inc Company Information
- Chief Executive Officer
- Marlan D. Walker J.D.
- Headquarters
- 951 Yamato Road, Boca Raton, FL, United States, 33431
- Website
- www.therapeuticsmd.com
- Phone
- 561 961 1900
- IPO / Founded
- 2003-12-11
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic